Robert W. Baird Lowers Cigna Group (NYSE:CI) Price Target to $315.00

Cigna Group (NYSE:CI) had its price target reduced by analysts at Robert W. Baird from $372.00 to $315.00 in a research note issued to investors on Thursday,MarketScreener reports. The brokerage currently has an “outperform” rating on the health services provider’s stock. Robert W. Baird’s price objective indicates a potential upside of 14.67% from the stock’s previous close.

Other equities analysts have also recently issued reports about the stock. The Goldman Sachs Group lowered their price target on shares of Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a research note on Tuesday, November 4th. Jefferies Financial Group restated a “buy” rating and set a $310.00 target price on shares of Cigna Group in a research report on Monday, November 3rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a report on Monday. Morgan Stanley reissued an “overweight” rating and set a $355.00 price target on shares of Cigna Group in a research note on Friday, October 31st. Finally, Zacks Research downgraded Cigna Group from a “hold” rating to a “strong sell” rating in a research note on Monday, November 3rd. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $331.77.

Cigna Group Stock Performance

Shares of CI stock opened at $274.70 on Thursday. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The stock has a 50 day simple moving average of $280.44 and a 200-day simple moving average of $294.17. The company has a market cap of $73.38 billion, a price-to-earnings ratio of 12.12, a price-to-earnings-growth ratio of 0.99 and a beta of 0.26. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. The firm had revenue of $69.57 billion for the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.Cigna Group’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Insider Buying and Selling at Cigna Group

In related news, CEO David Cordani purchased 4,134 shares of the company’s stock in a transaction on Monday, November 3rd. The stock was bought at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the transaction, the chief executive officer owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This represents a 2.69% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the sale, the insider owned 51,182 shares in the company, valued at $15,354,600. This represents a 9.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Cigna Group

A number of large investors have recently bought and sold shares of the stock. Harbor Capital Advisors Inc. boosted its holdings in Cigna Group by 119.5% in the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after acquiring an additional 49 shares during the last quarter. Flaharty Asset Management LLC acquired a new stake in Cigna Group during the 1st quarter valued at $28,000. 1248 Management LLC purchased a new stake in shares of Cigna Group during the first quarter worth about $29,000. Solstein Capital LLC acquired a new position in shares of Cigna Group in the second quarter worth about $29,000. Finally, Activest Wealth Management boosted its stake in shares of Cigna Group by 360.0% during the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after buying an additional 72 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.